GH Research Analyst Price Targets

Wall Street analyst price targets and consensus rating for GH Research (GHRS).

Price Target Range — 11 Quarters

Analyst Consensus — 10 Analysts

2S.Buy

8Buy

Consensus RatingBuy# Analysts10Avg. Consensus PT$41Upside to Avg. PT+122.9%

Rating Trend — Last 9 Months

Recent Analyst Actions

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
Aug 7, 2026	Guggenheim	Eddie Hickman	PT Raise	Buy	$34→$40
Aug 7, 2026	Cantor Fitzgerald	Charles Duncan	PT Raise	Overweight	$35→$40
Aug 6, 2026	Needham	Ami Fadia	PT Raise	Buy	$32→$39
Jul 27, 2026	Wells Fargo	Benjamin Burnett	Initiate	Overweight	$44
May 19, 2026	HC Wainwright & Co.	Patrick R. Trucchio	PT Cut	Buy	$70→$65
May 15, 2026	Cantor Fitzgerald	Charles Duncan	PT Raise	Overweight	$25→$35
May 15, 2026	Citizens	Jason N. Butler	PT Cut	Market Outperform	$42→$39
Mar 6, 2026	Citizens	Jason N. Butler	PT Raise	Market Outperform	$39→$42
Mar 6, 2026	Needham	Ami Fadia	PT Raise	Buy	$31→$32
Mar 2, 2026	HC Wainwright & Co.	Patrick R. Trucchio	PT Raise	Buy	$35→$70
Jan 23, 2026	RBC Capital	Brian Abrahams	PT Raise	Outperform	$33→$40
Jan 6, 2026	Canaccord Genuity	Sumant Kulkarni	PT Raise	Buy	$35→$39
Jan 6, 2026	Needham	Ami Fadia	PT Raise	Buy	$19→$29
Jan 5, 2026	Needham	Ami Fadia	Maintained	Buy	$19
Nov 10, 2025	HC Wainwright & Co.	Patrick R. Trucchio	PT Cut	Buy	$40→$35
Oct 13, 2025	Needham	Ami Fadia	Initiate	Buy	$19
Jun 24, 2025	JMP Securities	Jason Butler	Maintained	Market Outperform	$39
May 9, 2025	Guggenheim	Yatin Suneja	PT Cut	Buy	$32→$29
May 9, 2025	HC Wainwright & Co.	Patrick Trucchio	Maintained	Buy	$40
Mar 13, 2025	Guggenheim	Eddie Hickman	Initiate	Buy	$32

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
Guggenheim Maintains Buy on GH Research, Raises Price Target to $40

Guggenheim analyst Eddie Hickman maintains GH Research (NASDAQ:GHRS) with a Buy and raises the price target from $34 to $40.

Benzinga Newsdesk

PRO
Cantor Fitzgerald Maintains Overweight on GH Research, Raises Price Target to $40

Cantor Fitzgerald analyst Charles Duncan maintains GH Research (NASDAQ:GHRS) with a Overweight and raises the price target from $35 to $40.

Benzinga Newsdesk

PRO
Needham Maintains Buy on GH Research, Raises Price Target to $39

Needham analyst Ami Fadia maintains GH Research (NASDAQ:GHRS) with a Buy and raises the price target from $32 to $39.

Benzinga Newsdesk

PRO
Wells Fargo Initiates Coverage On GH Research with Overweight Rating, Announces Price Target of $44

Wells Fargo analyst Benjamin Burnett initiates coverage on GH Research (NASDAQ:GHRS) with a Overweight rating and announces Price Target of $44.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Maintains Buy on GH Research, Lowers Price Target to $65

HC Wainwright & Co. analyst Patrick R. Trucchio maintains GH Research (NASDAQ:GHRS) with a Buy and lowers the price target from $70 to $65.

Benzinga Newsdesk

These Analysts Revise Their Forecasts On GH Research After Q1 Results

GH Research (NASDAQ:GHRS) reported a larger loss than expected in Q1. Analysts lowered price targets, stock fell 3.4%. CEO noted progress in GH001 program.

Avi Kapoor

GH Research PLC

GH Research Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
Guggenheim Maintains Buy on GH Research, Raises Price Target to $40

PRO
Cantor Fitzgerald Maintains Overweight on GH Research, Raises Price Target to $40

PRO
Needham Maintains Buy on GH Research, Raises Price Target to $39

PRO
Wells Fargo Initiates Coverage On GH Research with Overweight Rating, Announces Price Target of $44

PRO
HC Wainwright & Co. Maintains Buy on GH Research, Lowers Price Target to $65

These Analysts Revise Their Forecasts On GH Research After Q1 Results

People Also Watch

People Also Watch

GH Research PLC

GH Research Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROGuggenheim Maintains Buy on GH Research, Raises Price Target to $40

PROCantor Fitzgerald Maintains Overweight on GH Research, Raises Price Target to $40

PRONeedham Maintains Buy on GH Research, Raises Price Target to $39

PROWells Fargo Initiates Coverage On GH Research with Overweight Rating, Announces Price Target of $44

PROHC Wainwright & Co. Maintains Buy on GH Research, Lowers Price Target to $65

These Analysts Revise Their Forecasts On GH Research After Q1 Results

People Also Watch

People Also Watch

PRO
Guggenheim Maintains Buy on GH Research, Raises Price Target to $40

PRO
Cantor Fitzgerald Maintains Overweight on GH Research, Raises Price Target to $40

PRO
Needham Maintains Buy on GH Research, Raises Price Target to $39

PRO
Wells Fargo Initiates Coverage On GH Research with Overweight Rating, Announces Price Target of $44

PRO
HC Wainwright & Co. Maintains Buy on GH Research, Lowers Price Target to $65